These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10718918)

  • 1. Evidence that hydrogen sulphide can modulate hypothalamo-pituitary-adrenal axis function: in vitro and in vivo studies in the rat.
    Dello Russo C; Tringali G; Ragazzoni E; Maggiano N; Menini E; Vairano M; Preziosi P; Navarra P
    J Neuroendocrinol; 2000 Mar; 12(3):225-33. PubMed ID: 10718918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y; Aguilera G
    Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin inhibits basal and stimulated corticotropin-releasing hormone release from the rat hypothalamus via a nontranscriptional mechanism.
    Tringali G; Pozzoli G; Lisi L; Navarra P
    Endocrinology; 2007 Oct; 148(10):4711-5. PubMed ID: 17615151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticotrophin-releasing hormone and pituitary ACTH release in vitro.
    Calogero AE; Raiti F; Nicolosi G; Burrello N; D'Agata R; Mantero F
    J Endocrinol; 1994 Mar; 140(3):419-24. PubMed ID: 8182369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin.
    Wren AM; Small CJ; Fribbens CV; Neary NM; Ward HL; Seal LJ; Ghatei MA; Bloom SR
    Neuroendocrinology; 2002 Nov; 76(5):316-24. PubMed ID: 12457042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic melatonin treatment counteracts glucocorticoid-induced dysregulation of the hypothalamic-pituitary-adrenal axis in the rat.
    Konakchieva R; Mitev Y; Almeida OF; Patchev VK
    Neuroendocrinology; 1998 Mar; 67(3):171-80. PubMed ID: 9630434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat.
    Bernardini R; Chiarenza A; Kamilaris TC; Renaud N; Lempereur L; Demitrack M; Gold PW; Chrousos GP
    Neuroendocrinology; 1994 Nov; 60(5):503-8. PubMed ID: 7845540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
    Korbonits M; Little JA; Forsling ML; Tringali G; Costa A; Navarra P; Trainer PJ; Grossman AB
    J Neuroendocrinol; 1999 Jul; 11(7):521-8. PubMed ID: 10444309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
    Calogero AE; Kamilaris TC; Johnson EO; Tartaglia ME; Chrousos G
    Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
    Moidel MA; Belz EE; Czambel RK; Rubin RT; Rhodes ME
    J Pharmacol Toxicol Methods; 2006; 53(3):264-71. PubMed ID: 16311047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH.
    Bagdy G; Calogero AE; Szemeredi K; Chrousos GP; Gold PW
    Regul Pept; 1990 Nov; 31(2):83-92. PubMed ID: 2176309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.
    Mozid AM; Tringali G; Forsling ML; Hendricks MS; Ajodha S; Edwards R; Navarra P; Grossman AB; Korbonits M
    Horm Metab Res; 2003 Aug; 35(8):455-9. PubMed ID: 12953161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1beta-induced hypothalamic pituitary adrenal axis responses.
    Buller K; Xu Y; Dayas C; Day T
    Neuroendocrinology; 2001 Feb; 73(2):129-38. PubMed ID: 11244300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antalarmin, a novel corticotropin-releasing hormone antagonist, on the dynamic function of the preterm ovine fetal hypothalamo-pituitary-adrenal axis.
    Young IR; Chan EC; Smith R; Chrousos GP; Veldhuis JD; Canny BJ
    Neuroendocrinology; 2002 Jul; 76(1):47-54. PubMed ID: 12097816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide.
    Tringali G; Greco MC; Lisi L; Pozzoli G; Navarra P
    Peptides; 2012 Apr; 34(2):353-9. PubMed ID: 22342595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway.
    Navarra P; Tsagarakis S; Faria MS; Rees LH; Besser GM; Grossman AB
    Endocrinology; 1991 Jan; 128(1):37-44. PubMed ID: 1846105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex and strain variability in the rat hypothalamo-pituitary-adrenal (HPA) axis function.
    Chisari A; Carino M; Perone M; Gaillard RC; Spinedi E
    J Endocrinol Invest; 1995 Jan; 18(1):25-33. PubMed ID: 7759781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
    Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.